What's new

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Open

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Open

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Open

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Open

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2020

Policy

Open

Positioning Statements on Physician-led Switching for Biosimilar Medicines

19 September 2019

Policy

Positioning Statements on Physician-led Switching for Biosimilar Medicines BIOSIMILAR MEDICINES […]

Read more

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

11 September 2019

Policy

Open

Medicines for Europe Commentary on the Draft EMA regulatory science strategy 2025

28 June 2019

Policy

Open

Medicines For Europe Country Specific Market Access Policies

24 May 2018

Policy

Open

Position paper on Best Procurement Practices

28 April 2018

Policy

Open

Subscribe to our newsletter